FDA Drug information
Xarelto
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Xarelto RIVAROXABAN 10 mg/1 Aphena Pharma Solutions - Tennessee, LLC
- Xarelto RIVAROXABAN 10 mg/1 Cardinal Health 107, LLC
- Xarelto RIVAROXABAN 10 mg/1 Cardinal Health 107, LLC
- Xarelto RIVAROXABAN 10 mg/1 Janssen Pharmaceuticals, Inc.
- Xarelto RIVAROXABAN 10 mg/1 Janssen Pharmaceuticals, Inc.
- Xarelto RIVAROXABAN 15 mg/1 Cardinal Health 107, LLC
- Xarelto RIVAROXABAN 15 mg/1 Cardinal Health 107, LLC
- Xarelto RIVAROXABAN 15 mg/1 Janssen Pharmaceuticals, Inc.
- Xarelto RIVAROXABAN 15 mg/1 Janssen Pharmaceuticals, Inc.
- Xarelto RIVAROXABAN 155 mg/1 Janssen Pharmaceuticals, Inc.
- Xarelto RIVAROXABAN 155 mg/1 Janssen Pharmaceuticals, Inc.
- XARELTO RIVAROXABAN 2.5 mg/1 Janssen Pharmaceuticals, Inc.
- XARELTO RIVAROXABAN 2.5 mg/1 Janssen Pharmaceuticals, Inc.
- Xarelto RIVAROXABAN 20 mg/1 Cardinal Health 107, LLC
- Xarelto RIVAROXABAN 20 mg/1 Cardinal Health 107, LLC
- Xarelto RIVAROXABAN 20 mg/1 Janssen Pharmaceuticals, Inc.
- Xarelto RIVAROXABAN 20 mg/1 Janssen Pharmaceuticals, Inc.
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.